Novel transcript, antisense to CD97 (None)

The "novel transcript, antisense to CD97" (ENSG00000267379) is a long noncoding RNA (lncRNA) gene identified in the human genome and is transcribed antisense to the CD97 coding gene. Antisense transcripts such as this can regulate expression of their corresponding sense gene (in this case, CD97) by mechanisms including chromatin modification, transcriptional interference, and modulation of transcript stability[2][5][10][11]. Although widespread and functionally important as a type of gene expression regulatory RNA, these transcripts are not typically considered classical therapeutic targets such as receptors or enzymes, and no drugs are reported to directly interact with this particular transcript. Antisense lncRNAs have emerged as significant in fine-tuning cellular processes, but specific molecular and disease roles for ENSG00000267379 remain largely uncharacterized, with suggestive links to immune cell contexts due to CD97 function[4][1].

Other names

ENSG00000267379Novel transcript, antisense to CD97

Not applicable. As a noncoding RNA, it is not directly targeted by drugs; experimental approaches have used antisense oligonucleotides to modulate the function of other NATs, but not specifically this one